MX2010001612A - Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34). - Google Patents
Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34).Info
- Publication number
- MX2010001612A MX2010001612A MX2010001612A MX2010001612A MX2010001612A MX 2010001612 A MX2010001612 A MX 2010001612A MX 2010001612 A MX2010001612 A MX 2010001612A MX 2010001612 A MX2010001612 A MX 2010001612A MX 2010001612 A MX2010001612 A MX 2010001612A
- Authority
- MX
- Mexico
- Prior art keywords
- rhpth
- discloses
- present
- escherichia coli
- novel
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000000746 purification Methods 0.000 title abstract 2
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 title 1
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 title 1
- 102000058004 human PTH Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 102000005593 Endopeptidases Human genes 0.000 abstract 1
- 108010059378 Endopeptidases Proteins 0.000 abstract 1
- 101900264058 Escherichia coli Beta-galactosidase Proteins 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 108010049264 Teriparatide Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000005277 cation exchange chromatography Methods 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000004237 preparative chromatography Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 abstract 1
- 229960005460 teriparatide Drugs 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente invención describe un procedimiento para la preparación de rh(PTH) (1-34) también conocido como teriparatida por medio de la construcción de un nucleótido novedoso, como un fragmento NcoI.lXol como se establece en SEQ. ID. NO.: 1 que codifica una proteína de fusión quimérica como se establece en SEQ. ID. NO.: 2 que comprende un miembro de fusión que consiste en 41 aminoácidos que pertenecen al gen ß- galactosidasa (LacZ) Escherichia coIi, un sitio de escisión endopeptidasa, fragmento del gen rhPTH(1-34), clonando dicho nucleótido en un vector de expresión bajo el control del promotor T7, transformando Escherichia coli con dicho vector y expresando la proteína de fusión quimérica en fermentación alimentada por lotes; la presente invención además describe una inducción de lactosa con baja velocidad de alimentación para expresión optimizada de rhPTH(1-34)en Escherichia coli; la presente invención también describe un procedimiento de purificación ortogonal de dos pasos, novedoso y único para rhPTH(1-34) que comprende una cromatografía de intercambio catiónico opcionalmente seguida por cromatografía preparativa seleccionada de HIC o RP-HPLC para producir una proteína objetivo con pureza del =99%; la presente invención describe un método ambientalmente benigno, efectivo en cuanto a costo y simple para producir rhPTH(1-34) de alta pureza.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1543MU2007 | 2007-08-09 | ||
| PCT/IN2007/000573 WO2009019715A1 (en) | 2007-08-09 | 2007-12-06 | Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001612A true MX2010001612A (es) | 2010-07-01 |
Family
ID=39719206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001612A MX2010001612A (es) | 2007-08-09 | 2007-12-06 | Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34). |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8298789B2 (es) |
| EP (1) | EP2173768B1 (es) |
| KR (1) | KR20100053547A (es) |
| BR (1) | BRPI0721943A2 (es) |
| CA (1) | CA2694562A1 (es) |
| MX (1) | MX2010001612A (es) |
| RU (1) | RU2441019C2 (es) |
| WO (1) | WO2009019715A1 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107941983A (zh) * | 2018-01-05 | 2018-04-20 | 北京博康健基因科技有限公司 | 一种rhPTH蛋白或rhPTH蛋白制剂的检测方法和纯度的分析方法 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ302526B6 (cs) * | 2010-05-13 | 2011-06-29 | Zentiva, K.S. | Rekombinantní produkce teriparatidu v bakteriích Escherichia coli |
| MX2013013224A (es) * | 2011-05-18 | 2014-04-25 | Swedish Orphan Biovitrum Ab Publ | Procedimiento de purificacion de proteinas de bajo ph. |
| AR094276A1 (es) | 2012-12-21 | 2015-07-22 | Alkem Laboratories Ltd | Marcadores de fusion y sistema de vector de expresion para la expresion de hormona paratiroides humana (rhpth) |
| SG11201600511QA (en) * | 2013-08-21 | 2016-02-26 | Cadila Healthcare Ltd | Purification process for pth |
| ES2612427T3 (es) * | 2014-02-11 | 2017-05-16 | Richter-Helm Bio Tec Gmbh & Co. Kg | Método para purificar teriparatida (PTH1-34) |
| RU2017123283A (ru) | 2014-12-01 | 2019-01-09 | Пфенекс Инк. | Партнеры по слиянию для получения пептидов |
| US9975941B2 (en) * | 2015-11-11 | 2018-05-22 | Richter-Helm Bio Tec Gmbh & Co. Kg | Method for purifying teriparatide |
| CN107066788B (zh) * | 2016-12-07 | 2020-11-24 | 辽宁科技大学 | 一种用制备色谱分离复杂物中目标物的优化方法 |
| CN107501408B (zh) * | 2017-09-22 | 2021-11-02 | 扬子江药业集团四川海蓉药业有限公司 | 一种特立帕肽的制备方法 |
| CN110734503B (zh) * | 2019-11-22 | 2021-12-21 | 浙江省林业科学研究院 | 一种阿拉伯低聚半乳糖及其制备和应用 |
| CN112625117A (zh) * | 2020-12-23 | 2021-04-09 | 无锡和邦生物科技有限公司 | 一种可溶性重组特立帕肽的非变性纯化方法及应用 |
| CN117736962A (zh) * | 2023-12-08 | 2024-03-22 | 亿帆医药(上海)有限公司 | 发酵培养基及其在特立帕肽制备中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4086196A (en) | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
| WO1990010067A1 (de) | 1989-02-23 | 1990-09-07 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung |
| DE69111371T2 (de) | 1990-09-28 | 1996-03-14 | Takeda Chemical Industries Ltd | Synthetisches Gen für menschliches Parathyroidhormon. |
| US5208041A (en) | 1991-05-23 | 1993-05-04 | Allelix Biopharmaceuticals Inc. | Essentially pure human parathyroid hormone |
| JP3531947B2 (ja) | 1991-08-19 | 2004-05-31 | 第一サントリーファーマ株式会社 | ペプチドの製造方法 |
| US5496801A (en) | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
| KR100230578B1 (ko) | 1997-07-25 | 1999-12-01 | 허영섭 | 포스포리불로키나제를 융합파트너로 이용하는 재조합 인간 부갑상선호르몬의 발현벡터 |
| CA2315103A1 (en) | 1997-12-18 | 1999-06-24 | Eli Lilly And Company | Crystalline teriparatide |
| CN1163510C (zh) * | 2000-03-02 | 2004-08-25 | 上海复旦张江生物医药股份有限公司 | 甲状旁腺激素衍生物及其制备方法 |
| WO2003100022A2 (en) * | 2002-05-24 | 2003-12-04 | Restoragen, Inc. | Methods and dna constructs for high yield production of polypeptides |
| CN1807456B (zh) | 2005-01-19 | 2012-09-05 | 丁邦 | 重组人甲状旁腺激素pth1-34的制备方法 |
-
2007
- 2007-12-06 MX MX2010001612A patent/MX2010001612A/es active IP Right Grant
- 2007-12-06 EP EP07870535.7A patent/EP2173768B1/en not_active Not-in-force
- 2007-12-06 WO PCT/IN2007/000573 patent/WO2009019715A1/en not_active Ceased
- 2007-12-06 US US12/452,919 patent/US8298789B2/en not_active Expired - Fee Related
- 2007-12-06 KR KR1020107002579A patent/KR20100053547A/ko not_active Ceased
- 2007-12-06 CA CA2694562A patent/CA2694562A1/en not_active Abandoned
- 2007-12-06 BR BRPI0721943-1A2A patent/BRPI0721943A2/pt not_active IP Right Cessation
- 2007-12-06 RU RU2010108327/10A patent/RU2441019C2/ru not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107941983A (zh) * | 2018-01-05 | 2018-04-20 | 北京博康健基因科技有限公司 | 一种rhPTH蛋白或rhPTH蛋白制剂的检测方法和纯度的分析方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2441019C2 (ru) | 2012-01-27 |
| RU2010108327A (ru) | 2011-09-20 |
| US20100145033A1 (en) | 2010-06-10 |
| BRPI0721943A2 (pt) | 2014-03-18 |
| EP2173768B1 (en) | 2014-03-05 |
| EP2173768A1 (en) | 2010-04-14 |
| US8298789B2 (en) | 2012-10-30 |
| KR20100053547A (ko) | 2010-05-20 |
| CA2694562A1 (en) | 2009-02-12 |
| WO2009019715A1 (en) | 2009-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010001612A (es) | Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34). | |
| AU2012329967B2 (en) | Secretion production method for protein | |
| JP4857279B2 (ja) | カルボキシ末端をアミド化したペプチドの製造方法 | |
| Yang et al. | Expression and purification of the antimicrobial peptide cecropin AD by fusion with cationic elastin-like polypeptides | |
| Retnoningrum et al. | Codon optimization for high level expression of human bone morphogenetic protein–2 in Escherichia coli | |
| CN102282260A (zh) | 用于制备人重组胰岛素的方法 | |
| US20160168226A1 (en) | Process for production of insulin and insulin analogues | |
| CA2242086A1 (en) | Method of producing a 19p2 ligand | |
| Wang et al. | A novel strategy for the preparation of codon-optimized truncated Ulp1 and its simplified application to cleavage the SUMO fusion protein | |
| JP5673986B1 (ja) | タンパク質の沈殿による製造方法 | |
| WO2006012904B1 (en) | Polypeptides of botryosphaeria rhodina | |
| KR100468268B1 (ko) | 카메라단백질및프로세싱효소를사용한이의절단방법 | |
| WO1999005277A1 (en) | A recombinant expression vector of human parathyroid hormone using phosphoribulokinase as a fusion partner | |
| CA2052396C (en) | Synthetic gene coding for human parathyroid hormone | |
| WO2014097323A1 (en) | Novel fusion tags and expression vector system for the expression of human parathyroid hormone (rhpth) | |
| Ghasemi et al. | Using L-arabinose for production of human growth hormone in Escherichia coli, studying the processing of gIII:: hGH precursor | |
| Lee et al. | Efficient proteolytic cleavage by insertion of oligopeptide linkers and its application to production of recombinant human interleukin-6 in Escherichia coli | |
| US20090035815A1 (en) | Synthetic Gene for Enhanced Expression in E. Coli | |
| Parente et al. | Overproduction of soluble, extracellular cytotoxin α-sarcin inEscherichia coli | |
| KR20140135716A (ko) | 1→2 해독 프레임 이동의 감소 방법 | |
| MONTAZER et al. | Frequency of bovine lymphocyte antigen DRB3. 2 alleles in Sarabi cows | |
| KR101671626B1 (ko) | 신규한 단백질 분비용 발현 카세트 | |
| JP3252916B2 (ja) | ヒト副甲状腺ホルモンをコードする合成遺伝子 | |
| EP1646650A1 (en) | Recombinant igf expression systems | |
| KR20090108236A (ko) | 예시니아 페스티스 코리스메이트 뮤타아제 유전자의신호서열을 이용한 단백질 생산방법, 및 이를 위한 재조합발현벡터 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |